Archive for April 2024
Firebrick Pharma launches Nasodine in the US via Nasodine.com
17 Apr 2024
Firebrick Pharma (ASX:FRE) has launched its nasal spray product, Nasodine® Nasal Spray in the United States, the first country in the world where the product has become commercially available.
Nasodine Phase 2 COVID-19 Trial Results Published
02 Apr 2024
The Company is now advanced in our plans to introduce Nasodine in at least one international market.